Identification biomarkers for cervical cancer in peripheral blood lymphocytes by oligonucleotide microarrays

National Medical Journal of China

Volumn 90, Issue 37, 2010, Pages 2611-2615

  Sheng, Jie ^a   Zhang, Wei Yuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Oligonucleotide microarrays; Peripheral lymphocyte; Uterine cervical cancer

Indexed keywords

ENOLASE; ENOLASE 2; NUCLEOLIN; OLIGONUCLEOTIDE; TENASIN C; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN GENOME; PERIPHERAL LYMPHOCYTE; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; ADULT; BLOOD; CASE CONTROL STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; UTERINE CERVIX TUMOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84871419983     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.37.005     Document Type: Article

References (10)

1. Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55: 74-108.
2. Sova P, Feng Q H, Geiss G, et al. Discovery of novel methylation biomarkers in cervicalcarcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev, 2006, 15: 114-123.
3. Buvukbavram H, Arslan A. Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions. Int J Cancer, 2002, 100: 719-722.
4. Suwiwat S, Ricciardelli C, Tammi R, et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res, 2004, 10: 2491-2498.
5. Cazzaniga P, Nofroni I, Gandini O, et al. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer. Oncol Rep, 2005, 14: 1199-1202.
6. Harima Y, Ikeda K, Utsunomiya K, et al. Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis. Int J Radiat Oncol Biol Phys, 2009, 75: 1232-1239.
7. Aishima S, Taguchi K, Terashi T, et al. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol, 2003, 16: 1019-1027.
8. Sarkar S, Yong V W. Reduction of protein kinase C delta attenuates tenascin-C stimulated glioma invasion in three-dimensional matrix. Carcinogenesis, 2010, 31: 311-317.
9. Berndt A, Köllner R, Richter P, et al. A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies. Histochem Cell Biol, 2010, 133: 467-475.
10. Storck S, Shukla M, Dimitrov S, et al. Functions of the histone chaperone nucleolin in diseases. Subcell Biochem, 2007, 41: 125-144.